간질환 진단 시장 : 진단 방법별, 최종사용자별 - 세계 예측(2025-2030년)

The Liver Disease Diagnostics Market was valued at USD 9.94 billion in 2023, expected to reach USD 11.09 billion in 2024, and is projected to grow at a CAGR of 12.76%, to USD 23.05 billion by 2030.

The Liver Disease Diagnostics market focuses on tools and tests to diagnose liver diseases, including hepatitis, cirrhosis, and liver cancer. It involves biochemical tests, imaging techniques, and molecular diagnostics, essential for early disease detection, monitoring progression, and assessing treatment efficacy. The necessity of such diagnostics lies in the increasing prevalence of liver diseases driven by factors like alcohol consumption, obesity, and viral infections. The market serves healthcare settings, including hospitals, diagnostic labs, and research institutes, emphasizing personalized medicine and the rising demand for non-invasive techniques as critical applications.

Key growth factors influencing the market include advancements in technology, increasing awareness of liver conditions, and burgeoning demand for accurate diagnostic procedures. Innovations in genomics and proteomics are paving the way for more precise diagnostics, enhancing the potential for targeted therapies. Recent opportunities are emerging in the development of AI-driven diagnostic tools that improve accuracy and speed up the diagnostic process. Additionally, collaborations between biotech firms and healthcare providers are fostering the rapid development and adoption of novel diagnostic solutions.

Challenges include the high cost of advanced diagnostic tests, limited availability of skilled professionals, and regulatory hurdles that can slow down the introduction of new technologies. Pharmaceutical companies must also consider the potential resistance from a clinical community accustomed to established diagnostic methods. To optimize growth, innovation should focus on cost-effective, highly accurate, and easily deployable diagnostic tools. Research into liver microRNA as biomarkers, improved imaging technologies, and machine learning applications for data analysis are promising avenues for business expansion.

In essence, the liver disease diagnostics market holds significant growth potential, driven by technological advancements and an increasing need for precision medicine. By addressing cost and regulatory challenges and investing in cutting-edge research, companies can capture emerging opportunities and strengthen their market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Liver Disease Diagnostics Market

The Liver Disease Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in the Prevalence of Acute and Chronic Liver Diseases
  • Development of Government and Non-Government Awareness Programs
  • Consumer Inclination Towards Minimally Invasive Diagnostic Systems
• Market Restraints
  • High Cost of Diagnostic Devices and Lack of Skilled Professionals
• Market Opportunities
  • Technological Advancements in Diagnostic Systems
  • Improving Healthcare Access in Economies
• Market Challenges
  • Complexity Associated with Liver Diagnostic Systems

Porter's Five Forces: A Strategic Tool for Navigating the Liver Disease Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Liver Disease Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Liver Disease Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Liver Disease Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Liver Disease Diagnostics Market

A detailed market share analysis in the Liver Disease Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Liver Disease Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Liver Disease Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Liver Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bayer AG, Merck & Co., Inc., Boston Scientific Corporation, Randox Laboratories Ltd., Fujifilm Holdings Corporation, Perspectum Ltd., Koninklijke Philips N.V., Amgen Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, BioMerieux SA, Cook Medical Incorporated, Siemens Healthineers AG, Horiba, Ltd., Becton, Dickinson and Company, Ri.Mos. Srl, Hepatiq, Inc., Hologic, Inc., Argon Medical Devices, Inc., Epigenomics AG, Medtronic PLC, Thermo Fisher Scientific, Inc., and Quest Diagnostics Incorporated.

Market Segmentation & Coverage

This research report categorizes the Liver Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Diagnosis Technique, market is studied across Biopsy, Endoscopy, Imaging, and Laboratory Tests.
• Based on End-user, market is studied across Hospitals and Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the Prevalence of Acute and Chronic Liver Diseases
    • 5.1.1.2. Development of Government and Non-Government Awareness Programs
    • 5.1.1.3. Consumer Inclination Towards Minimally Invasive Diagnostic Systems
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Diagnostic Devices and Lack of Skilled Professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancements in Diagnostic Systems
    • 5.1.3.2. Improving Healthcare Access in Economies
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity Associated with Liver Diagnostic Systems
• 5.2. Market Segmentation Analysis
  • 5.2.1. Diagnosis Technique: Ongoing advances to improve imaging modalities for liver disease diagnosis
  • 5.2.2. End-user: Expansion of hospitals across the world supported by government initiatives for developing robust healthcare infrastructure
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Liver Disease Diagnostics Market, by Diagnosis Technique

• 6.1. Introduction
• 6.2. Biopsy
• 6.3. Endoscopy
• 6.4. Imaging
• 6.5. Laboratory Tests

7. Liver Disease Diagnostics Market, by End-user

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Laboratories

8. Americas Liver Disease Diagnostics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Liver Disease Diagnostics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Liver Disease Diagnostics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. E-Scopics Announces Commercial Launch Of Hepatoscope in the Us And Opens its Subsidiary in the US
  • 11.3.2. Stone Diagnostics to Provide Fibronostics Liver Disease Test
  • 11.3.3. Predictive Health Intelligence Launches Tool For Undiagnosed Liver Disease

Companies Mentioned

• 1. Abbott Laboratories
• 2. Bayer AG
• 3. Merck & Co., Inc.
• 4. Boston Scientific Corporation
• 5. Randox Laboratories Ltd.
• 6. Fujifilm Holdings Corporation
• 7. Perspectum Ltd.
• 8. Koninklijke Philips N.V.
• 9. Amgen Inc.
• 10. F. Hoffmann-La Roche Ltd.
• 11. Bio-Rad Laboratories, Inc.
• 12. Laboratory Corporation of America Holdings
• 13. BioMerieux SA
• 14. Cook Medical Incorporated
• 15. Siemens Healthineers AG
• 16. Horiba, Ltd.
• 17. Becton, Dickinson and Company
• 18. Ri.Mos. Srl
• 19. Hepatiq, Inc.
• 20. Hologic, Inc.
• 21. Argon Medical Devices, Inc.
• 22. Epigenomics AG
• 23. Medtronic PLC
• 24. Thermo Fisher Scientific, Inc.
• 25. Quest Diagnostics Incorporated